In a study by Amanzada and coworkers [14] among chronic hepatitis C patientsundergoing antiviral treatment, individuals with the EPO rs1617640 CCgenotype had a weaker rise of erythropoietin levels and a higher likelihood ofneeding blood transfusions. The gene discussed is EPO; the disease is chronic hepatitis C virus infection.